DISTRIBUTION OF BLOOD AND BLOOD COMPONENTS, INDICATIONS AND EARLY COMPLICATIONS OF TRANSFUSION

References (30)

1. Vengelen-Tyler V. Noninfectious Complications of Blood Transfusion. In: Technical Manual. 12th ed. Bethesda, MD: American Association of Blood Banks 1996: 558-9
2. Hillman RS, Kenneth AA: Blood Component Therapy. In: Hematology in Clinical practice 3rd ed. 2002: 407-16
3. Rossi EC, Simon EL, Moss GS, Gould SA. Principles of Transfusion Medicine. Baltimor: Williams and Wilkins, 1996: 747-812
4. Serious hazards of transfusion annual report 1999-2000. Manchester (UK): SHOT Office; accessed 2003 Dec 12.
5. Heddle NM, Kelton JG: Febrile nonhemolytic transfusion reactions, in Popovsky M (ed): Transfusion Reactions. Bethesda, MD, AABB Press, 2001, 45-82
6. Training Courses booklet of Society of Blood Centres and Transfusion. Indications for transfusion of blood and blood Components. İstanbul, 1998; 21.
7. Kılıç NB. I. National Blood Center and Transfusion Medicine Congress Book. Demand rate of whole blood and blood products. Nurol printing, Kapadokya, 2000.
8. Helper Y, Akalın H, Töre O. Blood Center of Uludag University Medical Faculty Hospital. Utilization of Blood Products in Medical Faculty of Uludag University. I. National Blood Center and Transfusion Medicine Congress Book. Nurol printing, Poster-24, Kapadokya, 2000.
9. Kaya E, Kuku İ, Harputluoğlu H, Özkan H.İ, Demircan M, Aydoğdu İ. Inonu University Medical Faculty, Turgut Ozal Medical Center Blood Bank. Blood Product Utilization in our bank. I. National Blood Center and Transfusion Medicine Congress Book. Nurol printing, Poster-29, Kapadokya, 2000.
10. Rao MP, Boralessa H, Morgan C, Soni N, Goldhill DR, Brett SJ, Boralessa H, Contreras M; North Thames Blood Interest Group. Anaesthesia 2002; 57:527-9.
11. Fernando Callera, Anita CO Silva, Alessandro F Moura, Djanete B Melo, Claudio MTP Melo – Revista. Brasileira de Hematologia e Hemoterapia-Descriptions of acute transfusion reactions in a Brazilian transfusion service-2004
12. Practice guidelines for blood component therapy. A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84:732-47
13. Walker RH. Special report: transfusion risks. Am J Clin Pathol 1987; 88:374-78
14. Heper Y, Töre O. Uludag University Medical Faculty Hospital Blood Center. Rate of transfusion reaction in the use whole blood and erythrocytes. I. National Blood Center and Transfusion Medicine Congress Book. Nurol printing, Poster-20, Kapadokya, 2000.
15. İleri T, Azık F, Çullas E, et al. Transfusion reactions of blood and blood products in children with leukemia. XXXI. National Congress Hematology Abstracts. Turk J Hematol 2004; 21: Supplement: 3;162
16. Christian N. Ezidiegwu MD. Karla J at al. Febrile Nonhemolytic Transfusion Reactions. Arch Pathol Lab Med 2004;28:991-95
17. Dzieczkowski JS, Barrett BB, Nester D, Campbell M, Cook J, Sugrue M, Andersen JW, Anderson KC. Characterization of reactions after exclusive transfusion of white cellreduced cellular blood components. Transfusion 1995;35:20-25
18. Federowicz I, Barrett BB, Andersen JW, Urashima M, Popovsky MA, Anderson KC. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996;36:21-28
19. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001;41: 997-1000
20. Anderson NA, Gray S, Copplestone JA, et al. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: Corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Trans Med 7:33-39, 1997
21. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794-97
22. Kelley DL, Mangini J, Lopez-Plaza I, et al. The utility of 3 day old whole blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions. Transfusion 2000; 40: 439-42
23. Sarkodee-Adoo CB, Kendall JM, Sridhara R, et al. The relationship between the duration of platelet storage and the development of transfusion reactions. Transfusion 1998;38:229-35
24. Hume HA, Popovsky MA, Benson K, et al. Hypotensive Reactions: a previously uncharacterized complication of platelet transfusion? Transfusion 1996;36:904-9
25. Sweeney JD, Dupuis M, Mega AJ. Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors. Transfusion 1998;38:410-11
26. Arslan Ö, Elkıran T, Arat M, İlhan O, Koç H. Severe hypotensive reaction due to a bedside white cell reduction filter (PXL 2KLE, Pall) Vox Sang 2000;78 (Suppl. 1):pp520
27. Fried MR, Eastlund T, Christie B. Hypotensive reactions to White cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy.Transfusion 1996; 36:900-3
28. Hall TL, Barnes A, Miller JR. Neonatal mortality following transfusion of red cells with with high plasma potassium levels. Transfusion 1993; 33: 606-9
29. Baz EM, Kanazi GE, Mahfouz RA, et al. An unusual case of hyperkalamia-induced cardiac arrest in a paediatric patient during transfusion of a ‘fresh’ 6-day-old blood unit. Transfus Med 2002;12:383-86
30. Uhl L, Kruskall MS. Complications of massive transfusion. In Popovsky MA, ed. Transfusion reactions, Bethesda: AABB Press, 2001: 339-57